Login Register Cart 0

Articles by Disease (Lung Cancer)

Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement

Journal: Current Drug Delivery
Volume: 17
Page: 1-1
Author(s): Dan Zou, Yajun Weng and Ping Yang*

Withdrawal Notice: Recent Advancements in Lung Cancer Treatment us-ing Receptor Targeting

Journal: Current Molecular Pharmacology
Volume: 14
Page: 1-1
Author(s): Harjit Singh, Bharat Khurana and Sukhbir Kaur*

WITHDRAWN: Stromal Cell-Derived Factor 1 Secreted by Cancer- Associated Fibroblasts Promotes lncRNA Xist through CXCR4 and Facilitates Invasion and Metastasis of Non-Small Cell Lung Cancer

Journal: Current Cancer Drug Targets
Volume: 22
Page: 1-1
Author(s): Lifang Wang, Wenhu Chen, Xiaoyan Li and Hongguang Zhao*

An Efficient Suppression of EGFR and B-Raf mRNA Overexpression in the Lung of Benzo[a]pyrene-induced mice by Cationic Lipo-ATRA Nanoformulation

Journal: Recent Patents on Nanotechnology
Volume: 18
Page: 1-9
Author(s): Berlin Grace V M*, David Wilson D, Siddikuzzaman, Viswanathan S, Ragavi R, Guruvayoorappan C and Kathirvelan C

Natriuretic Peptides in Gastrointestinal Cancer: Biomarkers and Potential Therapeutic Targets

Journal: Current Drug Research Reviews
Volume: 16
Page: 1-8
Author(s): Sajjad Sadeghpour, Mahla Velayati, Nima Zafari, Samaneh Mollazadeh, Shima Mehrabadi, Mina Maftooh, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A. Ferns, Mohammad Ali Kiani, Majid Khazaei and Amir Avan*

Role of Nanomedicine for Targeted Drug Delivery in Livestock: Future Prospective

Journal: Pharmaceutical Nanotechnology
Volume: 12
Page: 1-18
Author(s): Neeti Hooda, Aarti Ahlawat, Puja Kumari, Sabir Alam and Jamilur R. Ansari*

TPGS-modified Chitosan Nanoparticles of EGFR Inhibitor: Physicochemical and In vitro Evaluation against HepG2 Cell Lines

Journal: Current Drug Delivery
Volume: 21
Page: 1-14
Author(s): Mahendra Singh, Alka, Prashant Shukla, Zhi-Hong Wen, Chou-Yuan Ko and Ramachandran Vinayagam*

Implication of Thioredoxin 1 and Glutaredoxin 1 in H2O2-induced Phosphorylation of JNK and p38 MAP Kinases

Journal: Current Molecular Medicine
Volume: 24
Page: 1-15
Author(s): Efthymios Poulios*, Vasiliki Roupaka, Constantinos Giaginis, Dimitrios Galaris and Giannis Spyrou

Targeting Epigenetic Modifiers: Promising Strategies for Cancer Therapy and Beyond

Journal: Current Drug Therapy
Volume: 19
Page: 1-11
Author(s): Dilip Kumar Chanchal*, Prateek Porwal and Nidhi Mittal

LKB1 Mutations Enhance Radiosensitivity in Non-Small Cell Lung Cancer Cells by Inducing G2/M Cell Cycle Phase Arrest

Journal: Current Molecular Medicine
Volume: 24
Page: 1-8
Author(s): Yuanhu Yao*, Xiangnan Qiu, Meng Chen, Zhaohui Qin, Xinjun Zhang and Wei Zhang


© 2024 Bentham Science Publishers | Privacy Policy